UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 182 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$4,280,630
+22.9%
113,635
+60.6%
0.00%0.0%
Q1 2024$3,482,857
+37.3%
70,761
+1.8%
0.00%0.0%
Q4 2023$2,537,226
+99.7%
69,513
+26.5%
0.00%0.0%
Q3 2023$1,270,815
+15.8%
54,966
+28.9%
0.00%0.0%
Q2 2023$1,097,2960.0%42,6300.0%0.00%0.0%
Q1 2023$1,097,296
+56.7%
42,630
+58.4%
0.00%
Q4 2022$700,137
-99.9%
26,918
+12.1%
0.00%
Q3 2022$685,319,000
+75.0%
24,021
+51.0%
0.00%
Q2 2022$391,655,000
-66.8%
15,908
-23.9%
0.00%
-100.0%
Q1 2022$1,180,330,000
-8.9%
20,9130.0%0.00%
Q4 2021$1,296,188,000
-2.3%
20,9130.0%0.00%
-100.0%
Q3 2021$1,326,721,000
-23.0%
20,9130.0%0.00%0.0%
Q2 2021$1,723,440,000
+20.8%
20,913
+7.8%
0.00%0.0%
Q1 2021$1,427,258,000
+26.2%
19,400
+24.4%
0.00%0.0%
Q4 2020$1,131,312,000
+128.2%
15,600
+50.0%
0.00%
Q3 2020$495,768,00010,4000.00%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 5,831,307$429,009,00024.30%
Consonance Capital Management LP 1,201,399$88,387,0009.42%
Boxer Capital, LLC 2,075,905$152,724,0005.18%
Perceptive Advisors 4,849,912$356,808,0004.51%
Orbimed Advisors 6,186,307$455,127,0004.26%
Samsara BioCapital, LLC 169,852$12,496,0002.30%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,262,075$92,851,0001.37%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 558,574$41,094,0000.86%
SPHERA FUNDS MANAGEMENT LTD. 137,672$10,129,0000.78%
Affinity Asset Advisors, LLC 27,000$1,986,0000.67%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders